The pharma and medtech sectors are evolving rapidly, driven by science, technology, economics, politics and globalization. In the new industry landscape, creating strong brand strategies is ever more difficult and ever more vital. Brand Therapy gives pharma and medtech brand teams the tools to understand their market, create strong strategies and translate them into actionable plans. Written in 16 short, easy chapters, it is essential reading for anyone who works in or with brand teams in the life sciences industry.

Combination Therapy against Multidrug Resistance explores the potential of combination therapy as an efficient strategy to combat multi-drug resistance. Multidrug resistance (MDR) occurs when microorganisms such as bacteria, fungi, viruses, and parasites are excessively exposed to antimicrobial drugs such as antibiotics, antifungals, or antivirals, and in response the microorganism undergoes mutations or develops different resistance mechanisms to combat the drug for its survival. MDR is becoming an increasingly serious problem in both developed and developing nations. Bacterial resistance to antibiotics has developed faster than the production of new antibiotics, making bacterial infections increasingly difficult to treat, and the same is true for a variety of other diseases. Combination therapy proves to be a promising strategy as it offers potential benefits such as a broad spectrum of efficacy, greater potency than the drugs used in monotherapy, improved safety and tolerability, and reduction in the number of resistant organisms. This book considers how combination therapy can be applied in multiple situations, including cancer, HIV, tuberculosis, fungal infections, and more. Combination Therapy Against Multidrug Resistance gathers the most relevant information on the prospects of combination therapy as a strategy to combat multridrug resistance and helping to motivate the industrial sector and government agencies to invest more in research and development of this strategy as a weapon to tackle the multidrug resistance problem. It will be useful to academics and researchers involved in the development of new antimicrobial or antiinfective agents and treatment strtategies to combat multidrug resistance. Clinicians and medical nurses working in the field of infection prevention and control (IPC) will also find the book relevant

Carboxymethylcellulose (CMC), also known as cellulose gum, is manufactured by the chemical synthesis of naturally-derived cellulose with chloroacetic acid. The multifunctional aspects of this product make it favorable for use as a key intermediate or ingredient in several applications. Furthermore, CMC is incorporated as a binding, thickening, stabilizing, emulsifying, suspending, sizing and coating agent in various applications. Cellulose gum enhances the aesthetics of the finished product by imparting a smooth texture and modifies the viscosity of various foods and beverages, superabsorbent hydrogels (as in many personal care products), cosmetics and pharmaceuticals. Textiles, paper and board, oil and gas drilling, paints and adhesives, and soaps and detergents are other major applications in the global market. The present book thus covers a wide range of applications; hence, a great number of people, both academics and industrialists, may find topics of interest about CMC, as well as other cellulosics.Although there are many research publications, patents and reports on CMC, no books about it are yet available. The present book reviews some vital issues and topics on the latest scientific and technological advances in carboxymethylcellulose. This book will provide an essential source of information to readers, in the exploration of possible applications of CMC, and in the generation of new ideas for product development.The book is divided into two volumes: Carboxymethyl Cellulose: Volume I Synthesis and Characterization, and Carboxymethyl Cellulose: Volume II Pharmaceutical and Industrial Applications. The book contains a total of 32 entries on selected topics. Each chapter describes some specific issues and gives the current status of research and technology in the study of synthesis routes or design concepts, methods and fabrication strategies, characterization and applications of CMC products, as well as future prospects for research in the subject area.Highlights of this book include synthesis and formation mechanisms of CMC, structure property relationships, homogeneous and heterogeneous phase modification to create common and functional products, analysis and characterization, absorption and swelling mechanisms, stimuli-responsive and super-absorbency nature, and a wide range of multi-dimensional applications, including human consumption and uses.

Since the 1950s, the American pharmaceutical industry has been heavily criticized for its profit levels, the high cost of prescription drugs, drug safety problems, and more, yet it has, together with the medical profession, staunchly and successfully opposed regulation. "Pills, Power, and Policy" offers a lucid history of how the American drug industry and key sectors of the medical profession came to be allies against pharmaceutical reform. It details the political strategies they have used to influence public opinion, shape legislative reform, and define the regulatory environment of prescription drugs. Untangling the complex relationships between drug companies, physicians, and academic researchers, the book provides essential historical context for understanding how corporate interests came to dominate American health care policy after World War II.

In recent years, emerging trends in the design and development of drug products have indicated ever greater need for integrated characterization of excipients and in-depth understanding of their roles in drug delivery applications. This book presents a concise summary of relevant scientific and mechanistic information that can aid the use of excipients in formulation design and drug delivery applications. Each chapter is contributed by chosen experts in their respective fields, which affords truly in-depth perspective into a spectrum of excipient-focused topics. This book captures current subjects of interest - with the most up to date research updates - in the field of pharmaceutical excipients. This includes areas of interest to the biopharmaceutical industry users, students, educators, excipient manufacturers, and regulatory bodies alike.